Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk

Autor: Willeit, Peter, Tschiderer, Lena, Allara, Elias, Reuber, Kathrin, Seekircher, Lisa, Gao, Lu, Liao, Ximing, Lonn, Eva, Gerstein, Hertzel C, Yusuf, Salim, Brouwers, Frank P, Asselbergs, Folkert W, Van Gilst, Wiek, Anderssen, Sigmund A, Grobbee, Diederick E, Kastelein, John JP, Visseren, Frank LJ, Ntaios, George, Hatzitolios, Apostolos I, Savopoulos, Christos, Nieuwkerk, Pythia T, Stroes, Erik, Walters, Matthew, Higgins, Peter, Dawson, Jesse, Gresele, Paolo, Guglielmini, Giuseppe, Migliacci, Rino, Ezhov, Marat, Safarova, Maya, Balakhonova, Tatyana, Sato, Eiichi, Amaha, Mayuko, Nakamura, Tsukasa, Kapellas, Kostas, Jamieson, Lisa M, Skilton, Michael, Blumenthal, James A, Hinderliter, Alan, Sherwood, Andrew, Smith, Patrick J, Van Agtmael, Michiel A, Reiss, Peter, Van Vonderen, Marit GA, Kiechl, Stefan, Klingenschmid, Gerhard, Sitzer, Matthias, Stehouwer, Coen DA, Uthoff, Heiko, Zou, Zhi-Yong, Cunha, Ana R, Neves, Mario F, Witham, Miles D, Park, Hyun-Woong, Lee, Moo-Sik, Bae, Jang-Ho, Bernal, Enrique, Wachtell, Kristian, Kjeldsen, Sverre E, Olsen, Michael H, Preiss, David, Sattar, Naveed, Beishuizen, Edith, Huisman, Menno V, Espeland, Mark A, Schmidt, Caroline, Agewall, Stefan, Ok, Ercan, Aşçi, Gülay, De Groot, Eric, Grooteman, Muriel PC, Blankestijn, Peter J, Bots, Michiel L, Sweeting, Michael J, Thompson, Simon G, Lorenz, Matthias W, PROG-IMT And The Proof-ATHERO Study Groups

Publikováno v: Willeit, P, Tschiderer, L, Allara, E, Reuber, K, Seekircher, L, Gao, L, Liao, X, Lonn, E, Gerstein, H C, Yusuf, S, Brouwers, F P, Asselbergs, F W, van Gilst, W, Anderssen, S A, Grobbee, D E, Kastelein, J J P, Visseren, F L J, Ntaios, G, Hatzitolios, A I, Savopoulos, C, Nieuwkerk, P T, Stroes, E, Walters, M, Higgins, P, Dawson, J, Gresele, P, Guglielmini, G, Migliacci, R, Ezhov, M, Safarova, M, Balakhonova, T, Sato, E, Amaha, M, Nakamura, T, Kapellas, K, Jamieson, L M, Skilton, M, Blumenthal, J A, Hinderliter, A, Sherwood, A, Smith, P J, van Agtmael, M A, Reiss, P, van Vonderen, M G A, Kiechl, S, Klingenschmid, G, Sitzer, M, Stehouwer, C D A, Uthoff, H, Olsen, M H & PROG-IMT and the Proof-ATHERO Study Groups 2020, ' Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk : Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients ', Circulation, vol. 142, no. 7, pp. 621-642 . https://doi.org/10.1161/CIRCULATIONAHA.120.046361
Circulation, 142(7), 621-642. LIPPINCOTT WILLIAMS & WILKINS
Willeit, P, Tschiderer, L, Allara, E, Reuber, K, Seekircher, L, Gao, L, Liao, X, Lonn, E, Gerstein, H C, Yusuf, S, Brouwers, F P, Asselbergs, F W, Van Gilst, W, Anderssen, S A, Grobbee, D E, Kastelein, J J P, Visseren, F L J, Ntaios, G, Hatzitolios, A I, Savopoulos, C, Nieuwkerk, P T, Stroes, E, Walters, M, Higgins, P, Dawson, J, Gresele, P, Guglielmini, G, Migliacci, R, Ezhov, M, Safarova, M, Balakhonova, T, Sato, E, Amaha, M, Nakamura, T, Kapellas, K, Jamieson, L M, Skilton, M, Blumenthal, J A, Hinderliter, A, Sherwood, A, Smith, P J, Van Agtmael, M A, Reiss, P, Van Vonderen, M G A, Kiechl, S, Klingenschmid, G, Sitzer, M, Stehouwer, C D A, Uthoff, H, Zou, Z Y, Cunha, A R, Neves, M F, Witham, M D, Park, H W, Lee, M S, Bae, J H, Bernal, E, Wachtell, K, Kjeldsen, S E, Olsen, M H, Preiss, D, Sattar, N, Beishuizen, E, Huisman, M V, Espeland, M A, Schmidt, C, Agewall, S, Ok, E, Aşçi, G, De Groot, E, Grooteman, M P C, Blankestijn, P J, Bots, M L, Sweeting, M J, Thompson, S G & Lorenz, M W 2020, ' Carotid intima-media thickness progression as surrogate marker for cardiovascular risk : Meta-Analysis of 119 clinical trials involving 100 667 patients ', Circulation, vol. 142, no. 7, pp. 621-642 . https://doi.org/10.1161/CIRCULATIONAHA.120.046361
Circulation, 142(7), 621-642. Lippincott Williams and Wilkins

Background: To quantify the association between effects of interventions on carotid intima-media thickness (cIMT) progression and their effects on cardiovascular disease (CVD) risk. Methods: We systematically collated data from randomized, controlled

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b12f6fbaa10360ca86fdbefdaff247d
https://doi.org/10.1161/circulationaha.120.046361

Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy.

Autor: Blümer RM; Department of Endocrinology and Metabolism, the Netherlands., van Vonderen MG, Sutinen J, Hassink E, Ackermans M, van Agtmael MA, Yki-Jarvinen H, Danner SA, Reiss P, Sauerwein HP

Publikováno v: AIDS (London, England) [AIDS] 2008 Jan 11; Vol. 22 (2), pp. 227-36.